# The Effects of Platelet Rich Plasma Adjuvant to Type I/III Collagen Ratio, Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Pelvic Organ Prolapse Repair

> **NCT07150442** · NA · RECRUITING · sponsor: **Andalas University** · enrollment: 30 (estimated)

## Conditions studied

- Pelvic Organ Prolapse Vaginal Surgery
- Platelet Rich Plasma Injection

## Interventions

- **PROCEDURE:** POP surgery and PRP injection
- **PROCEDURE:** POP surgery and placebo injection

## Key facts

- **NCT ID:** NCT07150442
- **Lead sponsor:** Andalas University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-27
- **Primary completion:** 2026-04
- **Final completion:** 2026-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07150442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07150442, "The Effects of Platelet Rich Plasma Adjuvant to Type I/III Collagen Ratio, Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Pelvic Organ Prolapse Repair". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07150442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*